Venus Remedies Limited has scheduled a meeting of its Board of Directors for 26th October 2026. The primary agenda for the meeting includes:

  • Consideration and approval of the Unaudited Standalone Financial Results for the quarter ended 30th September 2026.
  • Consideration and approval of the Unaudited Consolidated Financial Results for the quarter ended 30th September 2026.
  • Any other business matters with the permission of the Chair.

Trading Window Closure

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, the company's trading window for designated persons has been closed from 1st October 2026. The closure will remain in effect until 48 hours after the declaration of the financial results to the public.